167 related articles for article (PubMed ID: 1371984)
1. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas.
Ghali VS; Jimenez EJ; Garcia RL
Hum Pathol; 1992 Jan; 23(1):21-5. PubMed ID: 1371984
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical study of leu 7 and PCNA expression in thyroid neoplasms.
Fucich LF; Freeman SM; Marrogi AJ
Biotech Histochem; 1996 Nov; 71(6):298-303. PubMed ID: 8957557
[TBL] [Abstract][Full Text] [Related]
3. Leu-7 immunoreactivity in cytologic specimens of thyroid lesions, with emphasis on follicular neoplasms.
Ostrowski ML; Brown RW; Wheeler TM; Green LK; Schaffner DL
Diagn Cytopathol; 1995 Jun; 12(4):297-302. PubMed ID: 7544717
[TBL] [Abstract][Full Text] [Related]
4. Intercellular adhesion molecule-1 (ICAM-1) immunoreactivity in well-differentiated thyroid papillary carcinomas.
Tanda F; Cossu A; Bosincu L; Manca A; Ibba M; Massarelli G
Mod Pathol; 1996 Jan; 9(1):53-6. PubMed ID: 8821957
[TBL] [Abstract][Full Text] [Related]
5. CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma.
Khan A; Baker SP; Patwardhan NA; Pullman JM
Virchows Arch; 1998 May; 432(5):427-32. PubMed ID: 9645441
[TBL] [Abstract][Full Text] [Related]
6. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
Schröder S; Wodzynski A; Padberg B
Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
[TBL] [Abstract][Full Text] [Related]
7. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms.
Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T
Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421
[TBL] [Abstract][Full Text] [Related]
8. Expression of keratin 19 distinguishes papillary thyroid carcinoma from follicular carcinomas and follicular thyroid adenoma.
Schelfhout LJ; Van Muijen GN; Fleuren GJ
Am J Clin Pathol; 1989 Nov; 92(5):654-8. PubMed ID: 2479256
[TBL] [Abstract][Full Text] [Related]
9. Tissue polypeptide antigen in thyroid tumours of follicular cell origin: an immunohistochemical re-evaluation for diagnostic purposes.
Tuccari G; Barresi G
Histopathology; 1990 Apr; 16(4):377-81. PubMed ID: 2361653
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of HBME-1, E-cadherin, and CD56 in the differential diagnosis of thyroid nodules.
Ozolins A; Narbuts Z; Strumfa I; Volanska G; Stepanovs K; Gardovskis J
Medicina (Kaunas); 2012; 48(10):507-14. PubMed ID: 23324246
[TBL] [Abstract][Full Text] [Related]
11. Immunocytochemical demonstration of melanotransferrin (p97) in thyroid tumors of follicular cell origin.
Barresi G; Tuccari G
Pathology; 1994 Apr; 26(2):127-9. PubMed ID: 8090582
[TBL] [Abstract][Full Text] [Related]
12. Loss of microsomal antigen in follicular and papillary carcinoma of the thyroid. An immunofluorescence and electron-microscopic study.
Pontius KI; Hawk WA
Am J Clin Pathol; 1980 Nov; 74(5):620-9. PubMed ID: 7004165
[TBL] [Abstract][Full Text] [Related]
13. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma.
Tomoda C; Kushima R; Takeuti E; Mukaisho K; Hattori T; Kitano H
Thyroid; 2003 Mar; 13(3):291-5. PubMed ID: 12729479
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3: presurgical marker of thyroid follicular epithelial cell-derived carcinomas.
Saggiorato E; Aversa S; Deandreis D; Arecco F; Mussa A; Puligheddu B; Cappia S; Conticello S; Papotti M; Orlandi F
J Endocrinol Invest; 2004 Apr; 27(4):311-7. PubMed ID: 15233548
[TBL] [Abstract][Full Text] [Related]
15. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland.
Gaffney RL; Carney JA; Sebo TJ; Erickson LA; Volante M; Papotti M; Lloyd RV
Am J Surg Pathol; 2003 Apr; 27(4):494-8. PubMed ID: 12657934
[TBL] [Abstract][Full Text] [Related]
16. CA 50 and CA 19-9 antigen expression in normal, hyperplastic, and neoplastic thyroid tissue.
Vierbuchen M; Schröder S; Uhlenbruck G; Ortmann M; Fischer R
Lab Invest; 1989 May; 60(5):726-32. PubMed ID: 2716285
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical diagnosis of papillary thyroid carcinoma.
Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
[TBL] [Abstract][Full Text] [Related]
18. Retinoblastoma expression in thyroid neoplasms.
Anwar F; Emond MJ; Schmidt RA; Hwang HC; Bronner MP
Mod Pathol; 2000 May; 13(5):562-9. PubMed ID: 10824929
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of S100C in thyroid lesions.
Torres-Cabala C; Panizo-Santos A; Krutzsch HC; Barazi H; Namba M; Sakaguchi M; Roberts DD; Merino MJ
Int J Surg Pathol; 2004 Apr; 12(2):107-15. PubMed ID: 15173915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]